Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04940299
Brief Title: Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

First Submitted : June 18, 2021
First Submitted that Met QC Criteria : June 18, 2021
First Posted : June 25, 2021

Last Update Submitted that Met QC Criteria : September 24, 2021
Last Update Posted : September 28, 2021